Combination of Bacteriophages and Antibiotics for Prevention of Vascular Graft Infections-An In Vitro Study

被引:3
|
作者
Ruemke, Stefan [1 ,2 ]
Rubalskii, Evgenii [1 ,2 ]
Salmoukas, Christina [1 ,2 ]
Hermes, Kristina [1 ,2 ]
Natanov, Ruslan [1 ]
Kaufeld, Tim [1 ]
Gryshkov, Oleksandr [2 ,3 ]
Mutsenko, Vitalii [2 ,3 ]
Rubalsky, Maxim [4 ]
Burgwitz, Karin [1 ,2 ]
Glasmacher, Birgit [2 ,3 ]
Haverich, Axel [1 ,2 ]
Rustum, Saad [1 ]
Kuehn, Christian [1 ,2 ]
机构
[1] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, D-30625 Hannover, Germany
[2] Lower Saxony Ctr Biomed Engn, Implant Res & Dev, D-30625 Hannover, Germany
[3] Leibniz Univ Hannover, Inst Multiphase Proc, D-30823 Hannover, Germany
[4] Astrakhan State Med Univ, Dept Microbiol & Virol, Astrakhan 414000, Russia
关键词
implant-associated infection; vascular graft; prevention; bacteriophage; antibiotics; fibrin glue; coating; INHIBITION; BACTERIA; PHAGE;
D O I
10.3390/ph16050744
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
(1) Background: Implant-associated bacterial infections are usually hard to treat conservatively due to the resistance and tolerance of the pathogens to conventional antimicrobial therapy. Bacterial colonization of vascular grafts may lead to life-threatening conditions such as sepsis. The objective of this study is to evaluate whether conventional antibiotics and bacteriophages can reliably prevent the bacterial colonization of vascular grafts. (2) Methods: Gram-positive and Gram-negative bacterial infections were simulated on samples of woven PET gelatin-impregnated grafts using Staphylococcus aureus and Escherichia coli strains, respectively. The ability to prevent colonization was evaluated for a mixture of broad-spectrum antibiotics, for strictly lytic species-specific bacteriophage strains, and for a combination of both. All the antimicrobial agents were conventionally tested in order to prove the sensitivity of the used bacterial strains. Furthermore, the substances were used in a liquid form or in combination with a fibrin glue. (3) Results: Despite their strictly lytic nature, the application of bacteriophages alone was not enough to protect the graft samples from both bacteria. The singular application of antibiotics, both with and without fibrin glue, showed a protective effect against S. aureus (0 CFU/cm(2)), but was not sufficient against E. coli without fibrin glue (M = 7.18 x 10(4) CFU/cm(2)). In contrast, the application of a combination of antibiotics and phages showed complete eradication of both bacteria after a single inoculation. The fibrin glue hydrogel provided an increased protection against repetitive exposure to S. aureus (p = 0.05). (4) Conclusions: The application of antibacterial combinations of antibiotics and bacteriophages is an effective approach to the prevention of bacteria-induced vascular graft infections in clinical settings.
引用
收藏
页数:18
相关论文
共 23 条
  • [1] Prevention of vascular graft infections after impregnation with pathogen-specific bacteriophages: an in vitro experimental model
    Bisdas, T.
    Bagaev, E.
    Burgwitz, K.
    Marsch, G.
    Wilhelmi, M.
    Haverich, A.
    Teebken, O. E.
    GEFASSCHIRURGIE, 2011, 16 (06): : 387 - 394
  • [2] Vascular graft infections:: In vitro and in vivo investigations of a new vascular graft with long-term protection
    Ueberrueck, T
    Zippel, R
    Tautenhahn, J
    Gastinger, I
    Lippert, H
    Wahlers, T
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2005, 74B (01) : 601 - 607
  • [3] Pre-clinical In Vitro Models of Vascular Graft Coating in the Prevention of Vascular Graft Infection: A Systematic Review
    Mufty, Hozan
    Van den Eynde, Jef
    Meuris, Bart
    Metsemakers, Willem-Jan
    Van Wijngaerden, Eric
    Vandendriessche, Thomas
    Steenackers, Hans P.
    Fourneau, Inge
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2022, 63 (01) : 119 - 137
  • [4] PREVENTION OF PROSTHETIC VASCULAR GRAFT INFECTION BY RIFAMPICIN IMPREGNATION OF A PROTEIN-SEALED DACRON GRAFT IN COMBINATION WITH PARENTERAL CEPHALOSPORIN
    AVRAMOVIC, J
    FLETCHER, JP
    JOURNAL OF CARDIOVASCULAR SURGERY, 1992, 33 (01) : 70 - 74
  • [5] The prevention and treatment of vascular graft infection with a Triclosan (Irgasan®)-bonded Dacron graft:: an experimental study in the pig
    Hernandez-Richter, T
    Schardey, HM
    Löhlein, F
    Heiss, MM
    Redondo-Müller, M
    Hammer, C
    Schildberg, FW
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2000, 20 (05) : 413 - 418
  • [6] In Vitro Study of Antimicrobial Percutaneous Nephrostomy Catheters for Prevention of Renal Infections
    Vargas-Cruz, Nylev
    Reitzel, Ruth A.
    Rosenblatt, Joel
    Jamal, Mohamed
    Szvalb, Ariel D.
    Chaftari, Anne-Marie
    Hachem, Ray
    Raad, Issam
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [7] Treatment of vascular graft infections: gentamicin-coated ePTFE grafts reveals strong antibacterial properties in vitro
    Lazic, Igor
    Obermeier, Andreas
    Dietmair, Bettina
    Kempf, Wolfgang E.
    Busch, Albert
    Tuebel, Jutta
    Schneider, Jochen
    Von Eisenhart-Rothe, Ruediger
    Biberthaler, Peter
    Burgkart, Rainer
    Pfoerringer, Dominik
    JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2022, 33 (03)
  • [8] In vitro study about prevention of vascular reocclusion by low intensity ultrasonic irradiation
    Sawaguchi, Yoshikazu
    Wang, Zuojun
    Yamamoto, Hiroyuki
    Nakata, Norio
    DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (05) : 233 - 239
  • [9] In-vitro-Effektivität der Imprägnierung von Gefäßprothesen mit keimspezifischen Bakteriophagen für die Prävention von ProtheseninfektionenPrevention of vascular graft infections after impregnation with pathogen-specific bacteriophages: an in vitro experimental model
    T. Bisdas
    E. Bagaev
    K. Burgwitz
    G. Marsch
    M. Wilhelmi
    A. Haverich
    O.E. Teebken
    Gefässchirurgie, 2011, 16 (6) : 387 - 394
  • [10] Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity
    Stenger, Michael
    Behr-Rasmussen, Carsten
    Klein, Kasper
    Gronnemose, Rasmus B.
    Andersen, Thomas Emil
    Klitgaard, Janne K.
    Kolmos, Hans Jorn
    Lindholt, Jes S.
    PLOS ONE, 2017, 12 (03):